一个区域系统,为ST升高心肌梗塞提供及时获得穿皮冠状动脉干预的机会
Timothy D Henry1, Scott W Sharkey, M Nicholas Burke
1Minneapolis Heart Institute Foundation, 920 E 28th St, Ste 40, Minneapolis, MN 55407, USA. henry003@umn.edu
Circulation
|August 4, 2007
概括
快速将ST升高心肌梗塞 (STEMI) 患者转移到皮肤冠状动脉干预 (PCI) 中心是安全的,也是可行的. 一个标准化的系统为STEMI患者提供了及时的PCI,即使是从远方医院转移的患者.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 紧急医疗 紧急医疗
背景情况:
- 穿皮冠状动脉干预 (PCI) 在ST升高心肌梗塞 (STEMI) 时优于纤维解析.
- 欧洲试验表明,PCI转移改善了结果和访问,但美国的转移时间往往很长.
- 这挑战了在美国转移PCI战略的实用性.
研究的目的:
- 评估基于PCI的标准化治疗系统对STEMI患者的可行性和安全性.
- 为了评估从210英里外的医院转移的STEMI患者的门到气球时间.
- 通过转移协议治疗高风险STEMI人群的结果.
主要方法:
- 开发了一个基于PCI的标准化治疗系统,用于30家离PCI中心210英里范围内的医院.
- 连续治疗了1345名STEMI患者 (2003年3月至2006年11月),其中包括1048个转移.
- 测量不同转移区 (<60英里和60-210英里) 的患者的门到气球的时间.
主要成果:
- 门到气球的平均时间为95分钟60英里以下,120分钟60-210英里.
- 该研究包括高风险人群:12.3%的心脏性休克,10.8%的心脏骤停,14.6%的老年人 (>80岁).
- 住院死亡率为4.2%,住院时间中位数为3天.
结论:
- 对于STEMI患者来说,快速转移系统是安全和可行的.
- 标准化协议使STEMI患者从距离210英里远的社区医院转移到有效的PCI.
- 这种综合转移系统可以改善STEMI患者及时获得PCI的机会.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753


